The research sheds new light on how this enzyme influences glucagon secretion in pancreatic alpha (α) cells, a process crucial ... in people with type 2 diabetes (T2D), glucagon levels are ...

Septerna has a market cap of $750mn and $130mn in cash and ST investments. Discover SEPN's groundbreaking drug discovery ...

Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

Intermittent fasting is becoming increasingly popular. But is it helpful for weight loss and other medical conditions?

Irvine-based medical device company Beta Bionics Inc. on Jan. 6 filed an S-1 with the Securities and Exchange Commission to list on the Nasdaq under the symbol “BBNX.” ...

Glucagon, produced by alpha (α) cells in the pancreas, works in tandem with insulin to maintain blood sugar balance. When blood sugar drops too low, glucagon raises it, ensuring stability. However, ...

Targeting mitochondrial retrograde signaling may therefore be promising in the treatment or prevention of metabolic disorders ...

Opens in a new tab or window AURORA, Colo. -- Pregnant patients with type 2 diabetes (T2D) treated with semaglutide (Ozempic) had mixed pregnancy outcomes, an observational study found.